NASDAQ: NGEN
Nervgen Pharma Corp Stock Ownership - Who owns Nervgen Pharma?

Insider buying vs selling

Have Nervgen Pharma Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NGEN insiders and whales buy or sell their stock.

NGEN Shareholders

What type of owners hold Nervgen Pharma Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pfg Investments LLC0.25%201,000$426.12kInstitution
Bank Of America Corp0.25%200,656$425.39kInstitution
Marshall Wace LLP0.25%200,359$424.76kInstitution
Royal Bank Of Canada 10.21%171,961$364.56kInstitution
Integrated Wealth Concepts LLC0.11%86,815$184.05kInstitution
Valley Forge Investment Consultants Inc Adv0.10%77,698$164.72kInstitution
Bank Of Montreal 20.08%62,900$133.35kInstitution
Captrust Financial Advisors0.08%62,367$132.22kInstitution
Ubs Group Ag0.08%61,517$130.42kInstitution
Osaic Holdings Inc0.05%39,991$84.78kInstitution

1 of 3

NGEN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NGEN2.09%0.00%
ACOG48.37%19.19%Net BuyingNet Buying
CRBP46.35%53.65%Net SellingNet Buying
TNYA25.03%38.16%Net SellingNet Selling
MENS0.60%33.35%

Nervgen Pharma Stock Ownership FAQ

Who owns Nervgen Pharma?

Nervgen Pharma (NASDAQ: NGEN) is owned by 2.09% institutional shareholders, 0.00% Nervgen Pharma insiders, and 97.91% retail investors. Pfg Investments LLC is the largest individual Nervgen Pharma shareholder, owning 201,000.00 shares representing 0.25% of the company. Pfg Investments LLC's Nervgen Pharma shares are currently valued at $426.12k.

If you're new to stock investing, here's how to buy Nervgen Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.